View all MTLS reports and link to our research disclaimer.
In our 2025 Top Pick piece, we highlighted Materialise as our best idea for the year and so far, the stock has delivered. It's up ~35% YTD, making it one of the best performers in our coverage. Yet, despite this strong run, we believe there’s still plenty of upside ahead. With 4Q24 earnings slated for Thursday, February 20th before markets open, we expect another quarter of solid execution, in line with what we’ve seen throughout 2024. However, our real excitement is in 2025, where we see momentum accelerating further across their medical, manufacturing and software business segments.
Below we’ll dive into the key catalysts we believe will drive continued growth and why we remain bullish on the name.